Retention of anergy and inhibition of antibody responses during acute gammaherpesvirus 68 infection

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 2965-2974

  Getahun, Andrew ^a   Smith, Mia J ^a   Kogut, Igor ^a   Van Dyk, Linda F ^a   Cambier, John C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CALCIUM MOBILIZATION; CD4+ T LYMPHOCYTE; CLONAL ANERGY; COMPENSATORY ANTIINFLAMMATORY RESPONSE SYNDROME; CONTROLLED STUDY; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS 68; HERPES VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ACUTE DISEASE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTE SUBSETS; CLONAL ANERGY; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 84866148826     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201407     Document Type: Article

References (70)

1. Wucherpfennig, K. W. 2001. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 108: 1097-1104. (Pubitemid 32995366)
2. von Herrath, M. G., and M. B. Oldstone. 1996. Virus-induced autoimmune disease. Curr. Opin. Immunol. 8: 878-885.
3. Wu, H. J., I. I. Ivanov, J. Darce, K. Hattori, T. Shima, Y. Umesaki, D. R. Littman, C. Benoist, and D. Mathis. 2010. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32: 815-827.
4. Rosén, A., P. Gergely, M. Jondal, G. Klein, and S. Britton. 1977. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267: 52-54.
5. Lardans, V., C. Godfraind, J. T. van der Logt, W. A. Heessen, M. D. Gonzalez, and J. P. Coutelier. 1996. Polyclonal B lymphocyte activation induced by mouse hepatitis virus A59 infection. J. Gen. Virol. 77: 1005-1009. (Pubitemid 26142335)
6. Coutelier, J. P., P. G. Coulie, P. Wauters, H. Heremans, and J. T. van der Logt. 1990. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J. Virol. 64: 5383-5388. (Pubitemid 20364529)
7. Hutt-Fletcher, L. M., N. Balachandran, and M. H. Elkins. 1983. B cell activation by cytomegalovirus. J. Exp. Med. 158: 2171-2176.
8. Woods, A., F. Monneaux, P. Soulas-Sprauel, S. Muller, T. Martin, A. S. Korganow, and J. L. Pasquali. 2007. Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance. J. Virol. 81: 12525-12534. (Pubitemid 350085866)
9. Sangster, M. Y., D. J. Topham, S. D'Costa, R. D. Cardin, T. N. Marion, L. K. Myers, and P. C. Doherty. 2000. Analysis of the virus-specific and non-specific B cell response to a persistent B-lymphotropic gammaherpesvirus. J. Immunol. 164: 1820-1828. (Pubitemid 30108735)
10. Hunziker, L., M. Recher, A. J. Macpherson, A. Ciurea, S. Freigang, H. Hengartner, and R. M. Zinkernagel. 2003. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4: 343-349. (Pubitemid 36432316)
11. Fairweather, D., C. M. Lawson, A. J. Chapman, C. M. Brown, T. W. Booth, J. M. Papadimitriou, and G. R. Shellam. 1998. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology 94: 263-270. (Pubitemid 28267485)
12. Mathieu, P. A., K. A. Gómez, J. P. Coutelier, and L. A. Retegui. 2004. Sequence similarity and structural homologies are involved in the autoimmune response elicited by mouse hepatitis virus A59. J. Autoimmun. 23: 117-126. (Pubitemid 39485793)
13. Barton, E., P. Mandal, and S. H. Speck. 2011. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 29: 351-397.
14. Stevenson, P. G., and P. C. Doherty. 1998. Kinetic analysis of the specific host response to a murine gammaherpesvirus. J. Virol. 72: 943-949. (Pubitemid 28116871)
15. Cambier, J. C., S. B. Gauld, K. T. Merrell, and B. J. Vilen. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7: 633-643. (Pubitemid 47123549)
16. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962. (Pubitemid 44894955)
17. Teague, B. N., Y. Pan, P. A. Mudd, B. Nakken, Q. Zhang, P. Szodoray, X. Kim-Howard, P. C. Wilson, and A. D. Farris. 2007. Cutting edge: Transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus. J. Immunol. 178: 7511-7515. (Pubitemid 46898017)
18. Gauld, S. B., R. J. Benschop, K. T. Merrell, and J. C. Cambier. 2005. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol. 6: 1160-1167. (Pubitemid 41541794)
19. Goodnow, C. C., R. Brink, and E. Adams. 1991. Breakdown of self-tolerance in anergic B lymphocytes. Nature 352: 532-536. (Pubitemid 21912378)
20. Ward, N. S., B. Casserly, and A. Ayala. 2008. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin. Chest Med. 29: 617-625, viii.
21. Adib-Conquy, M., and J. M. Cavaillon. 2009. Compensatory anti-inflammatory response syndrome. Thromb. Haemost. 101: 36-47.
22. Benschop, R. J., K. Aviszus, X. Zhang, T. Manser, J. C. Cambier, and L. J. Wysocki. 2001. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14: 33-43. (Pubitemid 32144685)
23. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
24. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122. (Pubitemid 29359962)
25. Madsen, L., N. Labrecque, J. Engberg, A. Dierich, A. Svejgaard, C. Benoist, D. Mathis, and L. Fugger. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl. Acad. Sci. USA 96: 10338-10343. (Pubitemid 29422559)
26. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al. 1992. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360: 225-231.
27. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742. (Pubitemid 23114658)
28. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
29. Clambey, E. T., H. W. Virgin, IV, and S. H. Speck. 2000. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74: 1973-1984. (Pubitemid 30434056)
30. van Berkel, V., B. Levine, S. B. Kapadia, J. E. Goldman, S. H. Speck, and H. W. Virgin, IV. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J. Clin. Invest. 109: 905-914. (Pubitemid 34275111)
31. Virgin, H. W., IV, P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71: 5894-5904. (Pubitemid 27304926)
32. Getahun, A., and B. Heyman. 2009. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand. J. Immunol. 70: 277-287.
33. Jerne, N. K., and A. A. Nordin. 1963. Plaque formation in agar by single antibody-producing cells. Science 140: 405.
34. Nguyen, Y., B. A. McGuffie, V. E. Anderson, and J. B. Weinberg. 2008. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology 380: 182-190.
35. Collins, C. M., J. M. Boss, and S. H. Speck. 2009. Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J. Virol. 83: 6484-6493.
36. Flaño, E., I. J. Kim, D. L. Woodland, and M. A. Blackman. 2002. Gammaherpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J. Exp. Med. 196: 1363-1372. (Pubitemid 35375555)
37. Stevenson, P. G., and P. C. Doherty. 1999. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J. Virol. 73: 1075-1079. (Pubitemid 29036758)
38. Usherwood, E. J., A. J. Ross, D. J. Allen, and A. A. Nash. 1996. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J. Gen. Virol. 77: 627-630. (Pubitemid 26121794)
39. Evans, A. G., J. M. Moser, L. T. Krug, V. Pozharskaya, A. L. Mora, and S. H. Speck. 2008. A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J. Exp. Med. 205: 669-684. (Pubitemid 351439312)
40. Parry, C. M., J. P. Simas, V. P. Smith, C. A. Stewart, A. C. Minson, S. Efstathiou, and A. Alcami. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191: 573-578.
41. Martin, A. P., C. Canasto-Chibuque, L. Shang, B. J. Rollins, and S. A. Lira. 2006. The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J. Immunol. 177: 7296-7302. (Pubitemid 44715099)
42. Guggemoos, S., D. Hangel, S. Hamm, A. Heit, S. Bauer, and H. Adler. 2008. TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J. Immunol. 180: 438-443.
43. Michaud, F., F. Coulombe, E. Gaudreault, J. Kriz, and J. Gosselin. 2010. Involvement of TLR2 in recognition of acute gammaherpesvirus-68 infection. PLoS ONE 5: e13742.
44. Gargano, L. M., J. M. Moser, and S. H. Speck. 2008. Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J. Virol. 82: 3853-3863. (Pubitemid 351521222)
45. Jin, L., P. M. Waterman, K. R. Jonscher, C. M. Short, N. A. Reisdorph, and J. C. Cambier. 2008. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28: 5014-5026.
46. Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
47. Zhong, B., Y. Yang, S. Li, Y. Y. Wang, Y. Li, F. Diao, C. Lei, X. He, L. Zhang, P. Tien, and H. B. Shu. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29: 538-550.
48. Larson, J. D., J. M. Thurman, A. V. Rubtsov, D. Claypool, P. Marrack, L. F. van Dyk, R. M. Torres, and R. Pelanda. 2012. Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity. Proc. Natl. Acad. Sci. USA 109: E1092-E1100.
49. Coleman, C. B., M. S. Nealy, and S. A. Tibbetts. 2010. Immature and transitional B cells are latency reservoirs for a gammaherpesvirus. J. Virol. 84: 13045-13052.
50. Siegel, A. M., J. H. Herskowitz, and S. H. Speck. 2008. The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog. 4: e1000039.
51. Liang, X., C. M. Collins, J. B. Mendel, N. N. Iwakoshi, and S. H. Speck. 2009. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog. 5: e1000677.
52. Benedict, C. A., C. De Trez, K. Schneider, S. Ha, G. Patterson, and C. F. Ware. 2006. Specific remodeling of splenic architecture by cytomegalovirus. PLoS Pathog. 2: e16.
53. Mueller, S. N., K. A. Hosiawa-Meagher, B. T. Konieczny, B. M. Sullivan, M. F. Bachmann, R. M. Locksley, R. Ahmed, and M. Matloubian. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317: 670-674. (Pubitemid 47229967)
54. Howard, R. J., and J. S. Najarian. 1974. Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin. Exp. Immunol. 18: 109-118.
55. McChesney, M. B., R. S. Fujinami, P. W. Lampert, and M. B. Oldstone. 1986. Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J. Exp. Med. 163: 1331-1336. (Pubitemid 16000430)
56. Mosier, D. E., R. A. Yetter, and H. C. Morse, III. 1985. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161: 766-784. (Pubitemid 15083776)
57. Ceglowski, W. S., B. P. Campbell, and H. Friedman. 1975. Immunosuppression by leukemia viruses. Effect of Friend leukemia virus on humoral immune competence of leukemia-resistant C57BL/6 mice. J. Immunol. 114: 231-236.
58. Reed, S. G., S. B. Roters, and E. A. Goidl. 1983. Spleen cell-mediated suppression of IgG production to a non-parasite antigen during chronic Trypanosoma cruzi infection in mice. J. Immunol. 131: 1978-1982. (Pubitemid 13007848)
59. Albright, J. W., J. F. Albright, and D. G. Dusanic. 1978. Mechanisms of trypanosome-mediated suppression of humoral immunity in mice. Proc. Natl. Acad. Sci. USA 75: 3923-3927. (Pubitemid 8399843)
60. Suzuki, Y., and A. Kobayashi. 1983. Suppression of unprimed T and B cells in antibody responses by irradiation-resistant and plastic-adherent suppressor cells in Toxoplasma gondii-infected mice. Infect. Immun. 40: 1-7. (Pubitemid 13163030)
61. Valdez, J. C., O. E. Meson, G. A. de Valdez, and A. Sirena. 1984. Suppression of humoral response during the course of Candida albicans infection in mice. Mycopathologia 88: 61-63. (Pubitemid 15222451)
62. Hoffmann, M. K., O. Weiss, S. Koenig, J. A. Hirst, and H. F. Oettgen. 1975. Suppression and enhancement of the T cell-dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide. J. Immunol. 114: 738-741.
63. Rearte, B., V. Landoni, E. Laborde, G. Fernández, and M. Isturiz. 2010. Differential effects of glucocorticoids in the establishment and maintenance of endotoxin tolerance. Clin. Exp. Immunol. 159: 208-216.
64. Miyashita, T., M. J. McIlraith, A. C. Grammer, Y. Miura, J. F. Attrep, Y. Shimaoka, and P. E. Lipsky. 1997. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions. J. Immunol. 158: 4620-4633. (Pubitemid 127483780)
65. Callard, R. E., J. Herbert, S. H. Smith, R. J. Armitage, and K. E. Costelloe. 1995. CD40 cross-linking inhibits specific antibody production by human B cells. Int. Immunol. 7: 1809-1815.
66. Blair, P. A., K. A. Chavez-Rueda, J. G. Evans, M. J. Shlomchik, A. Eddaoudi, D. A. Isenberg, M. R. Ehrenstein, and C. Mauri. 2009. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182: 3492-3502.
67. Gasper-Smith, N., I. Marriott, and K. L. Bost. 2006. Murine gamma-herpesvirus 68 limits naturally occurring CD4+CD25+ T regulatory cell activity following infection. J. Immunol. 177: 4670-4678. (Pubitemid 44469800)
68. Meakins, J. L., J. B. Pietsch, O. Bubenick, R. Kelly, H. Rode, J. Gordon, and L. D. MacLean. 1977. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann. Surg. 186: 241-250. (Pubitemid 8170965)
69. Cohen, J. I. 2000. Epstein-Barr virus infection. N. Engl. J. Med. 343: 481-492. (Pubitemid 30646489)
70. Smith, K. A., S. Efstathiou, and A. Cooke. 2007. Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J. Immunol. 179: 7325-7333.